1. Home
  2. CASS vs ABVX Comparison

CASS vs ABVX Comparison

Compare CASS & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASS
  • ABVX
  • Stock Information
  • Founded
  • CASS 1906
  • ABVX 2013
  • Country
  • CASS United States
  • ABVX France
  • Employees
  • CASS N/A
  • ABVX N/A
  • Industry
  • CASS Business Services
  • ABVX
  • Sector
  • CASS Consumer Discretionary
  • ABVX
  • Exchange
  • CASS Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • CASS 567.9M
  • ABVX 511.3M
  • IPO Year
  • CASS 1996
  • ABVX N/A
  • Fundamental
  • Price
  • CASS $41.36
  • ABVX $5.97
  • Analyst Decision
  • CASS Buy
  • ABVX Buy
  • Analyst Count
  • CASS 1
  • ABVX 4
  • Target Price
  • CASS $46.00
  • ABVX $31.50
  • AVG Volume (30 Days)
  • CASS 43.9K
  • ABVX 320.0K
  • Earning Date
  • CASS 07-17-2025
  • ABVX 03-24-2025
  • Dividend Yield
  • CASS 2.99%
  • ABVX N/A
  • EPS Growth
  • CASS N/A
  • ABVX N/A
  • EPS
  • CASS 1.53
  • ABVX N/A
  • Revenue
  • CASS $220,944,000.00
  • ABVX $11,444,012.00
  • Revenue This Year
  • CASS N/A
  • ABVX $284.20
  • Revenue Next Year
  • CASS $7.19
  • ABVX N/A
  • P/E Ratio
  • CASS $27.44
  • ABVX N/A
  • Revenue Growth
  • CASS 4.54
  • ABVX 128.98
  • 52 Week Low
  • CASS $37.99
  • ABVX $4.77
  • 52 Week High
  • CASS $47.14
  • ABVX $14.22
  • Technical
  • Relative Strength Index (RSI)
  • CASS 42.28
  • ABVX 38.44
  • Support Level
  • CASS $40.98
  • ABVX $5.75
  • Resistance Level
  • CASS $42.02
  • ABVX $8.57
  • Average True Range (ATR)
  • CASS 0.80
  • ABVX 0.55
  • MACD
  • CASS -0.16
  • ABVX -0.17
  • Stochastic Oscillator
  • CASS 15.97
  • ABVX 7.69

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. It operates in two segments: Information Services and Banking Services. The firm generates maximum revenue from the Information Services segment, which provides transportation, energy, telecommunication, and environmental invoice processing and payment services to large corporations.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: